Coeliac Disease Trial, Recruiting NCT07556328 Sponsor: Tampere University Hospital Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT07556328
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You are already scheduled to have a camera examination of your upper digestive system (a procedure where a thin tube with a camera is passed through your mouth to look at your stomach and small intestine)
  • You are willing and able to sign a consent form before the procedure takes place
  • If you are in Group 1 (Healthy Controls): Your blood tests do not show signs of coeliac disease and coeliac disease is not suspected
  • If you are in Group 2 (Coeliac Diagnostics): You have been referred to have coeliac disease investigated for the first time, which requires a small tissue sample to be taken from your small intestine
  • If you are in Group 3 (Refractory Injury): You have been confirmed to have damage to the lining of your small intestine that has not improved despite following a strict gluten-free diet

Who may not be able to join:

  • If you are in Group 1 (Healthy Controls): You have another condition affecting your small intestine that causes damage to its lining, such as Crohn's disease or small intestinal ulcers
  • You are not able to sign a written consent form for any reason
  • You do not wish to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +358443400330

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tampere University Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
31 December 2035

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Villus-to-crypt ratio; Transcriptomic

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov